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Developing an 
antimicrobial resistance 
reference laboratory and 
surveillance programme 
in Vietnam
The Fleming Fund was established 
by the UK Government in 2015 in 
response to recommendations of an 
independent review on antimicrobial 
resistance (AMR) led by economist 
Jim O’Neill and the Global Action 
Plan on AMR adopted by the World 
Health Assembly in 2015.1 These 
recommendations were subsequently 
endorsed by the General Assembly of 
the Food and Agriculture Organisation 
(FAO) and World Organisation for 
Animal Health (OIE).
The Fleming Fund represents 
a £265 million investment from 
2015 to 2022, aimed at improving 
laboratory capacity for diagnosis and 
surveillance of AMR and antibiotic 
use in low-income and middle-
income countries where AMR has a 
disproportionate effect. The Fleming 
Fund is part of the UK Government’s 
Official Development Assistance 
budget and is administered by the 
Department of Health. The Mott 
MacDonald Group was appointed in 
2016 to manage the Fleming Fund’s 
projects and a fellowship scheme 
that will provide support to create a 
sustainable community of practice 
within investment countries. Itad has 
been appointed as an independent 
evaluator.
Following existing early investment 
in Vietnam, the Fleming Fund will 
expand into over 20 countries across 
sub-Saharan Africa, and south and 
southeast Asia. Grants are also provided 
to multilateral organisations, including 
WHO, the FAO, and the OIE, to assist 
countries with the development of 
AMR national action plans.
AMR has been recognised as a 
major health threat in Vietnam for 
over two decades. A situation analysis 
was completed in 2010 by the Global 
Antibiotic Resistance Partnership 
(GARP) Vietnam National Working 
Group,2 led by the National Hospital 
of Tropical Diseases (NHTD) and the 
Oxford University Clinical Research Unit 
(OUCRU), with representation from the 
Vietnamese Ministries of Health and 
of Agriculture and Rural Development. 
In 2013, the Vietnamese Ministry of 
Health developed a national action 
plan on AMR, and was the first country 
in the WHO Western Pacific region to 
do so. The plan is comprehensive and 
follows the priorities as outlined by 
WHO.3 Surveillance of antibiotic use and 
antibiotic resistance, and an antibiotic 
stewardship programme are among 
its priorities. In 2015, the Ministries 
of Health, Agriculture and Rural 
Development, Industry and Trade, and 
Natural Resources and Environment 
in Vietnam, and WHO, the FAO, and 
the OUCRU signed an aide memoire 
committing to help coordinate and 
jointly implement the national action 
plans across different sectors.4
A Fleming Fund grant was awarded 
in 2015 to the NHTD, the OUCRU, the 
University of Oxford, and Public Health 
England, supported by WHO and 
the Vietnamese Minister of Health, 
to establish a nationwide hospital-
surveillance network and reference 
laboratory at the newly built site of 
the NHTD.
The surveillance network was 
established in 2013, known as 
the Viet Nam Resistance project 
(VINARES), and consists of 16 central 
and provincial-level hospitals.5 This 
network is now recognised by the 
Ministry of Health as the National AMR 
Surveillance Network.
Passive isolate-based surveillance 
with WHONET has started. Active and 
passive (case-based) surveillance of 
the results of antibiotic-susceptibility 
testing will be established on 
the basis of the WHO Global 
Antimicrobial Resistance Surveillance 
System (GLASS) and Fleming Fund 
guidelines.6 Guidelines from the US 
Clinical and Laboratory Standards 
Institute have been translated and 
provided to participating hospitals. 
All these hospitals are enrolled in 
the UK National External Quality 
Assessment Scheme (UKNEQAS) and 
monthly data on antibiotic usage are 
also collected. A parallel network of 
five dermatovenereology clinics was 
established to include surveillance of 
gonococci. Data are reported into a 
cloud-based server and in time will 
be shown on a public website. The 
investigators work together with the 
Ministry of Health, WHO, and Global 
Health Security funded partners 
(US Centers for Disease Control and 
Prevention and PATH) to support 
this network. Enrolment in GLASS is 
anticipated in 2018.
The newly established laboratory 
at NHTD (opening in 2017) will be 
a training and knowledge centre, 
in which confirmatory testing, 
molecular detection of resistance 
mechanisms, and whole genome 
sequencing will be done on isolates 
of interest from the surveillance 
sites (eg, all blood and cerebrospinal 
fluid isolates, Salmonella spp and 
Shigella spp isolates from stool, and 
Gram-negative organisms from 
patients with ventilator-associated 
pneumonia). Staff members are 
adapting and implementing protocols 
from the University of Oxford and 
Pubic Health England and three staff 
members have received training in 
Oxford on whole genome sequencing 
and bioinformatics. The Ministry of 
Health has yet to assign AMR reference 
functions to laboratories representing 
different regions of Vietnam.
The project in Vietnam is the first 
step in a substantial programme 
of support to countries bearing the 
heaviest burden of AMR infections. 
Lessons learned will be shared in 
regional meetings, engaging govern-
ment and foreign development 
partners in Laos and Cambodia, and 
will help to shape the wider roll-out of 
the Fleming Fund in late 2017.
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